Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year20252024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 3 . 19 . 2024 Press release AMWC 2024: Galderma to share new data from its leading injectable aesthetic portfolio 3 . 13 . 2024 Press release Galderma launches IPO on the SIX Swiss Exchange and sets price range 3 . 13 . 2024 News story Dr. Flor A. Mayoral: A story of creativity, passion and dermatological innovation with Galderma 3 . 12 . 2024 News story We’re inspired by our people 3 . 10 . 2024 Press release Galderma @ AAD 2024: new data demonstrate the long-term efficacy of nemolizumab in prurigo nodularis and its durability in atopic dermatitis 3 . 6 . 2024 Press release Galderma Announces Intention to Float on the SIX Swiss Exchange 2 . 29 . 2024 Press release Galderma announces record 2023 net sales of over 4 B USD and significant core EBITDA margin expansion 2 . 28 . 2024 Press release Galderma to showcase latest updates from its broad, innovative and leading dermatology portfolio at the 2024 American Academy of Dermatology annual meeting 2 . 28 . 2024 News story AAD 2024: scientific presentations supported by Galderma 2 . 14 . 2024 Press release Galderma announces regulatory filing acceptance for nemolizumab in prurigo nodularis and atopic dermatitis in the U.S. and EU 2 . 12 . 2024 Making an impact 2 . 8 . 2024 Press release Galderma takes the ‘Face of Cetaphil®’ to the runway at New York City fashion week Pagination Previous page Previous Page Next page Next Page